IWIda Ayu Sri Wijayanti

Ida Ayu Sri Wijayanti

*This is an algorithmically generated author record based on publicly available information.

Ida Ayu Sri Wijayanti has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimalisasi Kualitas Pendidikan Klinik melalui Evaluasi Sistem E-Learning pada Pendidikan Dokter Muda Fakultas Kedokteran Universitas Udayana

    by David Christopher Tjandra, Ledwin Meikel Wibisono, Cokorda Agung Wahyu Purnamasidhi, Ida Ayu Sri Wijayanti, Komang Ayu Witarini, Dewa Putu Gede Purwa Samatra

    Optimalisasi Kualitas Pendidikan Klinik melalui Evaluasi Sistem E-Learning pada Pendidikan Dokter Muda Fakultas Kedokteran Universitas Udayana


  • Open Access

    Headache in healthcare workers related to personal protective equipment use in COVID-19 referral hospital

    by Ida Ayu Sri Wijayanti, Ni Putu Ayu Putri Mahadewi, Putu Gede Sudira, Kumara Tini, Ni Made Susilawathi, I Made Oka Adnyana

    Background Studies show that wearing personal protective equipment (PPE) for long periods of time can lead to discomfort such as headaches, which could affect the performance of healthcare workers. The aim of this study was to determine the prevalence and risk factors of headaches related to PPE in healthcare workers at a COVID-19 referral hospital. Methods A cross-sectional study was conducted involving 174 healthcare workers in a COVID-19 referral hospital in Bali. We conducted interviews using a questionnaire that consisted of three main parts: characteristics of the subjects, PPE usage, and PPE-associated headaches. A multiple logistic regression was used to analyze the data. Results The analysis results showed that the PPE-associated headaches had a prevalence of 63.8% and were gradual in onset, pressure-like in quality (46%), and mild in intensity (80.1%). PPE level III-associated headache was the most common type. The majority of the participants had headaches up to 6 hours after using the protective gear, but improving within 15-30 minutes of removal and/or after pharmacotherapy. A Chi-squared analysis showed a statistically significant association between duration of PPE use, working units, and PPE levels (pConclusion The frequency of PPE-associated headache was high and the PPE level was a risk factor of headache among healthcare workers. Better strategies are needed to reduce the duration of PPE exposure so that the work performance and quality of life of healthcare workers are not significantly affected.

  • Open Access

    Migraine as a risk factor for ischemic stroke: a systematic review and meta-analysis of cohort studies

    by I Made Oka Adnyana, I Putu Eka Widyadharma, Eric Hartono Tedyanto, Ida Ayu Sri Wijayanti, Ni Putu Ayu Putri Mahadewi

    Background: Migraine and stroke are neurovascular diseases that have become a public health problem and a relatively high economic burden. The relationship between migraine and stroke has been described in the literature for a long time. Several studies reveal that migraine can be a risk factor for stroke. Methods: We systematically searched PubMed using the PRISMA method and keywords according to MeSH terms to prepare this systematic review. We included published articles discussing migraine as a risk factor for ischemic stroke with a cohort study design and English article and listed the statistical value of the study. Results: In our meta-analysis, we found that migraine significantly increases the incidence of ischemic stroke. There were 12 studies included in this systematic review, and a meta-analysis was performed. The results showed a significant association between migraine and ischemic stroke (HR 1.205, 95% CI 1.151–1.262 p = 0.000), migraine with aura and ischemic stroke (HR 1.442, 95% CI 1.241–1.675 p = 0.000), and migraine without aura and ischemic stroke (HR 1.126, 95% CI 1.048–1.211 p = 0.001). The exact mechanism of stroke caused by migraine is still unclear, although, in some theories, several mechanisms have been described that are thought to be the cause of stroke. Several important points of the cause of stroke in migraine are hemodynamic changes, endothelial dysfunction, cervical artery dissection, vascular reactivity, hypercoagulability, and abortive migraine drugs. Conclusions: Both migraine with aura and without aura are risk factors for ischemic stroke. Several mechanisms that may cause ischemic stroke in migraine have been described, of which CSD-induced endothelial dysfunction is the primary pathophysiology of ischemic stroke in migraine.


  • Open Access

    Case reports of cerebral sinus venous thrombosis in COVID-19 patients

    by Prysta Aderlia Sitanggang, Kumara Tini, Ni Made Susilawathi, Ida Ayu Sri Wijayanti, Putu Utami Dewi, Dewa Putu Gde Purwa Samatra

    Background: Coronavirus disease 2019 (COVID-19) pandemic has started in December 2019 and still ongoing. The disease has been expanding rapidly with a high variety of phenotypes from asymptomatic, mild respiratory tract infection, multiple organ system dysfunction, and death. Neurological manifestations also appear in patients with COVID-19, such as headache, seizures, a decrease of consciousness, and paralysis. The hypercoagulable state in patients with COVID-19 is associated with the thromboembolic incident including ischemic strokes, venous thromboembolism, pulmonary artery embolism, and many further. Cerebral sinus venous thrombosis (CSVT) is a rare neurovascular emergency that is often found in critically ill patients. We report two cases of CSVT with different onsets, neurologic manifestations, and prognoses. Case presentation: Two cases of cerebral sinus venous thrombosis in COVID-19 patients were reported, following respiratory, hematology, and coagulation disarrangements, which was triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The first patient, which was presented with a seizure, had hypertension and diabetes mellitus as comorbidities. The latter case had no comorbidity but showed more severe presentations of COVID-19 such as brain and lung thrombosis, although already had several days of intravenous anticoagulant administrations. These two cases also have a different course of disease and outcomes, which were interesting topics to study. Conclusions: CSVT is one of the neurological complications of the COVID-19 when the brainstem venous drainage is involved. Despite successful alteration to the negative result of SARS-CoV-2 through the rt-PCR test, thrombogenesis and coagulation cascade continuing. Therefore, a high level of neutrophil to lymphocyte ratio (NLR), D-dimer, fibrinogen, and C-reactive protein (CRP) are paramount indicators of poor prognosis.


  • Open Access

    Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2

    by Putu Lohita Rahmawati, Kumara Tini, Ni Made Susilawathi, Ia Sri Wijayanti, Dpg Purwa Samatra

    Rahmawati PL, et al. J Clin Neurol. 2021 Apr;17(2):155-163. https://doi.org/10.3988/jcn.2021.17.2.155


  • Open Access

    TATA LAKSANA PEMERIKSAAN NEUROLOGIS VIRTUAL DI ERA PANDEMI CORONA VIRUS DISEASE 2019

    by Ni Made Susilawathi, Kumara Tini, Ida Ayu Sri Wijayanti, Putu Lohita Rahmawati, Putu Gede Sudira, Dewa Putu Wisnu Wardhana, Dewa Putu Gde Purwa Samatra

    Latar Belakang: Pandemi Corona Virus Disease 2019 (COVID-19) dengan penularannya yang sangat cepat di seluruh dunia berdampak terhadap perubahan pelayanan kesehatan di bidang neurologi sebagai upaya mendukung program pengendalian penyakit ini. Tujuan: Merumuskan rekomendasi panduan pemeriksaan neurologis untuk pelayanan teleneurologi. Diskusi: Penyesuaian dalam pelaksanaan pelayanan neurologi perlu segera dilakukan dengan mengadopsi metode pelayanan dengan telemedicine terutama dalam tata cara pemeriksaan pasien dengan pembatasan fisik dan sosial sebagai salah satu langkah pencegahan infeksi SARS-CoV-2. Simpulan: Layanan teleneurologi perlu dikembangkan dalam pelayanan neurologi termasuk pengembangan prosedur pemeriksaan neurologis secara virtual.

  • Open Access

    Case Reports of Cerebral Sinus Venous Thrombosis in COVID-19 Patients

    by Prysta Aderlia Sitanggang, Kumara Tini, Ni Made Susilawathi, Ida Ayu Sri Wijaya, Putu Utami Dewi, Dewa Putu Gde Purwa Samatra

    Background: The outbreak of Coronavirus disease 2019 (COVID-19) has started in China since December 2019 and expanding worldwide rapidly with cases of respiratory tract infection and multiple system involvement. Neurological manifestations are not exempted following the reports from various sources about Ischemic and haemorrhagic stroke related to COVID-19, but the reports about cerebral sinus venous thrombosis (CSVT) are still rare.Case presentation: We would like to report two cases of cerebral sinus venous thrombosis in COVID-19 patients following the respiratory manifestations with profound haematological and coagulation disarrangement triggered by COVID-19 and these are assumed as underlying mechanism. These two cases also have different course of disease and outcome which are interesting.Conclusions: CSVT is one of neurological complication and COVID -19 manifestation that can have grave prognosis, if this involves the brainstem venous drainage. Thrombogenesis and coagulation cascades are prolonged despite successful alteration to negative result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) reverse transcription polymerase chain reaction (rt-PCR) test. Therefore, monitoring neutrophil to lymphocyte ration (NLR), D-dimer level, fibrinogen and C-reactive protein (CRP) is paramount as well as indicators of poor prognosis.